Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
860 studies found for:    "Psoriasis"
Show Display Options
Rank Status Study
1 Active, not recruiting Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
2 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Intervention: Drug: Etanercept
3 Completed Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Conditions: Psoriasis Vulgaris;   Plaque Psoriasis
Intervention: Drug: Daivobet® Gel
4 Completed A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: 122-0551;   Drug: Vehicle
5 Completed
Has Results
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis Vulgaris
Interventions: Drug: Taclonex Ointment and Hydrogel Patch;   Drug: Taclonex Ointment
6 Completed
Has Results
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Intervention: Drug: etanercept
7 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
8 Active, not recruiting IL-17 Role in Variants of Psoriasis
Conditions: Scalp Psoriasis;   Pustular Palmo-plantar Psoriasis;   Non-pustular Palmo-plantar Psoriasis;   Elbow Psoriasis;   Lower Leg Psoriasis
9 Recruiting A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
10 Completed A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: Halobetasol Propionate Lotion 0.05%;   Drug: Placebo
11 Active, not recruiting Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
Conditions: Psoriasis;;   Psoriatic Arthritis;;   Psoriasis Arthropatica
Interventions: Drug: Apremilast;   Drug: Placebo
12 Completed
Has Results
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Conditions: Psoriasis;   Plaque-type Psoriasis
Interventions: Drug: Apremilast 10mg;   Drug: Apremilast 20mg;   Drug: Apremilast 30 mg;   Drug: Placebo;   Drug: Apremilast 30mg
13 Completed Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Conditions: Actively Extending Plaque Psoriasis;   Moderate to Severe Plaque Psoriasis
Interventions: Drug: IMO-3100;   Drug: Saline for Injection
14 Completed Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
Conditions: Psoriasis;   Plaque Psoriasis
Intervention: Drug: pazopanib (GW786034)
15 Completed Scalp Psoriasis Treatment With a Fiber Optic Comb
Condition: Psoriasis
Intervention: Device: UV-B Lightsource and Fiber Optic Comb
16 Completed LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris
Conditions: Psoriasis Vulgaris;   Plaque Psoriasis
Interventions: Drug: LEO 90100;   Drug: Vehicle
17 Completed
Has Results
A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)
Conditions: Psoriasis;   Plaque Psoriasis
Interventions: Drug: MK-0873 2% Cream;   Drug: MK-0873 vehicle (placebo) Cream;   Drug: Calcitriol Cream
18 Active, not recruiting Psoriasis Inflammation and Systemic Co Morbidities
Condition: Psoriasis
19 Active, not recruiting Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: TSO 2500;   Drug: TSO 7500
20 Completed Improving Psoriasis Through Health and Well-Being
Condition: Psoriasis
Interventions: Behavioral: Mindfulness-Based Stress Reduction;   Behavioral: Living Well

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years